Trial NCT04882163

View at ClinicalTrials.gov 
Org. Study IDs: CC-220-DLBCL-002
Secondary IDs: 2020-005333-32

Last trial update was posted on 2021-10-05

MeSH Interventions

Bendamustine Hydrochloride Dexamethasone Gemcitabine Lenalidomide Polatuzumab vedotin Rituximab

MeSH Conditions

Lymphoma Lymphoma, B-Cell

Other Conditions


Stopping Reasons

Business objectives have changed

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID